×
About 2,040 results

ALLMedicine™ Onychomycosis Center

Research & Reviews  543 results

Utility of polymerase chain reaction for assessment of onychomycosis during topical the...
https://doi.org/10.1111/ijd.16241
International Journal of Dermatology; Gupta AK, Cooper EA et. al.

May 11th, 2022 - Increased detection of fungi including non-dermatophyte molds (NDMs) using polymerase chain reaction (PCR) methods is well-established. However, the use of PCR to evaluate ongoing onychomycosis treatment outcome has not been investigated. Nail sam...

Fractional CO2 laser ablation leads to enhanced permeation of a fluorescent dye in heal...
https://doi.org/10.1002/lsm.23541
Lasers in Surgery and Medicine; Ortner VK, Nguyen N et. al.

Apr 23rd, 2022 - Conventional oral antifungal therapies for onychomycosis (OM) often do not achieve complete cure and may be associated with adverse effects, medical interactions, and compliance issues restricting their use in a large group of patients. Topical tr...

A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
https://clinicaltrials.gov/ct2/show/NCT05279846

Apr 20th, 2022 - Distal subungual onychomycosis (DSO) is the most common form of Onychomycosis, in which fungi invade the underside of the nail plate. The infection may worsen, spread to other uninfected areas or infect other people. Without treatment the disease ...

Factors Affecting Onychomycosis in Patients with Psoriasis.
https://doi.org/10.1111/dth.15513
Dermatologic Therapy; Yuksel Bozdemir N, Inan Yuksel E et. al.

Apr 16th, 2022 - Prevalence of onychomycosis increases in patients with psoriasis and that psoriasis predisposes to onychomycosis. It was aimed to determine the frequency of onychomycosis and responsible pathogens in patients with psoriasis, to reveal their differ...

Real-world effectiveness of a fractional CO2 laser with topical antifungal agents for t...
https://doi.org/10.1111/dth.15498
Dermatologic Therapy; Lee SK, Kim HY et. al.

Apr 8th, 2022 - Current therapeutic agents for onychomycosis have limited efficacy or cause side effects. Recently, successful treatment using fractional CO2 lasers has been reported; however, the results are inconsistent. We analyzed the real-world effectiveness...

see more →

Guidelines  1 results

Treatment of nail psoriasis: best practice recommendations from the Medical Board of th...
https://doi.org/10.1001/jamadermatol.2014.2983
JAMA Dermatology; Crowley JJ, Weinberg JM et. al.

Dec 5th, 2014 - Nail psoriasis can be difficult to treat and has a significant effect on quality of life. Relatively few controlled trials evaluating treatments for nail psoriasis have been published. There is an unmet need for treatment recommendations to guide ...

see more →

Drugs  124 results see all →

Clinicaltrials.gov  46 results

A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
https://clinicaltrials.gov/ct2/show/NCT05279846

Apr 20th, 2022 - Distal subungual onychomycosis (DSO) is the most common form of Onychomycosis, in which fungi invade the underside of the nail plate. The infection may worsen, spread to other uninfected areas or infect other people. Without treatment the disease ...

Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus
https://clinicaltrials.gov/ct2/show/NCT04993066

Mar 29th, 2022 - Demonstrate the safety and efficacy of the GentleMax Pro Plus™ laser system for its intended uses: hair removal including pseudofolliculitis barbae (PFB), clearance of pigmented and/or vascular lesions, temporary increase of clear nail in patients...

A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
https://clinicaltrials.gov/ct2/show/NCT04188574

Feb 23rd, 2022 - Onychomycosis (OM; fungal nail infection) is a common and contagious fungal infection of the nail plate or nail bed, leading to the gradual destruction of the nail plate. OM is considered the most prevalent of the nail ailments, accounting for abo...

To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis
https://clinicaltrials.gov/ct2/show/NCT05135910

Jan 5th, 2022 - Primary Efficacy: To identify patients achieving Complete Cure in the target toenail at Week 52. Secondary Efficacy: To identify patients that have achieved 1) Clinical Cure, 2) Mycological Cure, and/or 3) Positive Response in the target toenail a...

A Study to See if Low Level Laser Light Can Help to Treat Toenail Fungus
https://clinicaltrials.gov/ct2/show/NCT03066336

May 27th, 2021 - Nail onychomycosis, or fungus infection, is typically caused by a fungus called dermatophytes, but may also be caused by yeasts and molds. These microscopic organisms invade the skin through tiny invisible cuts or through a small separation betwee...

see more →

News  102 results

Separation and discoloration of thumb nail
https://www.mdedge.com/familymedicine/article/242637/dermatology/separation-and-discoloration-thumb-nail
MDedge Family Medicine;

Jul 22nd, 2021 - The color change in this case is subtle, but consistent with green nail syndrome also termed chloronychia. Green nail syndrome is a form of chronic paronychia caused by Pseudomonas aeruginosa and is associated with frequent water exposure.

Scaly patches on hand and feet
https://www.mdedge.com/familymedicine/article/240601/dermatology/scaly-patches-hand-and-feet
MDedge Family Medicine;

May 26th, 2021 - A potassium hydroxide (KOH) mount of skin scrapings from the patient’s feet and hand confirmed a diagnosis of unilateral tinea manuum and bilateral tinea pedis—the so-called 2-foot, 1-hand syndrome. Additionally, nail clippings from the patient’s.

Prescribing Patterns of Onychomycosis Therapies in the United States
https://www.mdedge.com/dermatology/article/233020/hair-nails/prescribing-patterns-onychomycosis-therapies-united-states
Eric J. Yang, MD, Shari R. Lipner, MD, PhD

Dec 7th, 2020 - To the Editor: Onychomycosis is the most common nail disorder, affecting approximately 5. 5% of the world’s population.

Paronychia and Target Lesions After Hematopoietic Cell Transplant
https://www.mdedge.com/dermatology/article/229812/wounds/paronychia-and-target-lesions-after-hematopoietic-cell-transplant
Jesus Alberto Cardenas-de la Garza, MD, Adrian Cuellar-Barboza, MD et. al.

Oct 12th, 2020 - The Diagnosis: Fusariosis A periodic acid-Schiff stain of the seropurulent drainage from a skin nodule revealed neutrophils and scarce branching hyaline hyphae. Skin and blood cultures grew a white cottony colony.

Three in Four Adults 70 and Older Have at Least One Skin Disease
https://www.staging.medscape.com/viewarticle/935774

Aug 17th, 2020 - (Reuters Health) - Skin diseases are highly prevalent among adults aged 70 years and older, with 75.7% of people in this age range reporting at least one skin disease requiring treatment or follow-up, a study in Finland suggests. Researchers exami...

see more →